Svetlana Grobarčíková1, Zora Lasabová2, Ján Kliment1
In this review article the authors analyze the importance of diagnosis of familial and hereditary prostate cancer in clinical practice. The terms of familial, hereditary and sporadic prostate cancer are defined; the impact of positive family history on diagnostic procedures in daily clinical use is established. Familial incidence is known to be related to higher risk of prostate cancer in other members of the affected family. More aggressive screening by earlier prostate specific antigen blood testing in this population is reasonable. With early diagnosis of familial or hereditary prostate cancers the prognosis of these patients remains comparable with cases of sporadic prostate cancer.